We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 631

Chancery Court Dismisses Derivative Suit Against Blue Bell Officers and Directors
  • K&L Gates
  • USA
  • November 13 2018

In Jack L. Marchand II v. John W. Barnhill, Jr., et al, the Delaware Chancery Court dismissed Plaintiff’s complaint under Court of Chancery Rule 23.1


SASB issues sustainability accounting standards for 77 industries
  • Cooley LLP
  • USA
  • November 13 2018

Way back in 2016, the SEC issued a Concept Release requesting comment on an enormous variety of potential changes to Reg S-K, including sustainability


Insights: Publications DE Chancery Court Finds Material Adverse Effect Allowed Fresenius to Terminate Merger Agreement with Akorn
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • October 22 2018

Summary: A perfect storm of facts in Akorn, Inc. v. Fresenius Kabi AG et al. allowed the Delaware Chancery Court to conclude that Fresenius could


Delaware Court of Chancery Issues Unprecedented Material Adverse Effect Ruling
  • Pepper Hamilton LLP
  • USA
  • October 3 2018

In a first-of-its-kind post-trial opinion, the Court of Chancery ruled on October 1 in Akorn, Inc. v. Fresenius Kabi AG, C.A. No. 2018-0300-JTL, that


Unsigned Contract Still a Written Contract
  • Masuda Funai Eifert & Mitchell Ltd
  • USA
  • August 30 2018

Can an unsigned contract still be a contract? The answer is yes, for statute of limitations purposes, says the 7th Circuit Court of Appeals. On this


Parent Company's Alleged Control of Subsidiary Insufficient to Establish Personal Jurisdiction
  • Masuda Funai Eifert & Mitchell Ltd
  • USA
  • August 16 2018

It is not uncommon for plaintiff’s counsel to assert creative theories in an effort to establish personal jurisdiction over a defendant in a


Board’s Failure to Adhere to Best Practices in Drug Clinical Trial Does Not Excuse Stockholder Demand as Futile
  • K&L Gates
  • USA
  • March 26 2018

In Wilkin v. Narachi, et al., and Orexigen Therapeutics, Inc., Civil Action No. 12412-VCMR (Del. Ch. February 28, 2018), the Delaware Court of


Hong Kong Announces Groundbreaking New Rules for Dual-Class Share, High-Tech and Biotech Company Listings
  • Skadden Arps Slate Meagher & Flom LLP
  • Hong Kong
  • February 26 2018

After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23


Delhi High Court upholds foreign award in favour of daiichi (except qua minor respondents)
  • Khaitan & Co
  • Singapore, India
  • February 6 2018

By a judgment delivered on 31 January 2018, the Delhi High Court has held that the award passed in favour of Daiichi Sankyo Company Ltd. (the


Inside the Courts - An Update From Skadden Securities Litigators
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • November 5 2017

Judge Patti B. Saris denied the Bank of New York Mellon’s (BNY Mellon) motion to strike putative class representative Ashby Henderson. BNY Mellon